Advertisement

Topics

ContraVir unveils positive data from mouse study for CRV431 in HBV

05:58 EDT 13 Jun 2019 | SmartBrief

ContraVir Pharmaceuticals announced the recent publication of the results of their hepatitis B virus candidate CRV431, which  -More

Original Article: ContraVir unveils positive data from mouse study for CRV431 in HBV

NEXT ARTICLE

More From BioPortfolio on "ContraVir unveils positive data from mouse study for CRV431 in HBV"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...